Expertise
Being an expert in what we do is our core value. Our team brings decades of institutional knowledge to every deal.
Plutus Investments
Investing In The Future
Strategically capitalising companies that redefine their sectors through innovation and operational excellence.
Being an expert in what we do is our core value. Our team brings decades of institutional knowledge to every deal.
We always make sure we deliver the best possible performance for our partners and portfolio companies.
We invest in very few companies, therefore we focus intently on our current portfolio to drive sustainable growth.

Proteocyte Diagnostics develops lab tests that predict oral cancer risk using AI-assisted biomarker analysis.
Swiss biotech developing a universal T cell supplement to improve the fitness and persistence of cancer cell therapies.
Biopharma company developing first-in-class therapies built around alternative splicing.
We provide capital that will allow your company to grow and we will be part of your journey until the exit.
We open our network to our portfolio companies and we integrate them as part of an ecosystem of global partners.
Our capital is patient and we do not have any time limit in terms of capital redemption, allowing for long-term value creation.
Reach out if you are looking to discuss co-investment opportunities or if you are a startup seeking to connect with Plutus Investments.